Older Mesothelioma Patients Not Necessarily at HIgher Risk from Surgery

783511_older couple

A new study from the University of Chicago has a positive message for older people with malignant pleural mesothelioma: Lung-sparing surgery may be no more risky for you than it is for younger patients, even if you have other health problems. The team performed a retrospective review of 117 consecutive mesothelioma patients who underwent the […]

New Mesothelioma Registry May Open Treatment Doors for Patients

24182041_woman patient

 It may soon be easier for mesothelioma patients to pinpoint the best treatment facilities and to access the highest level of care thanks to new legislation now making its way through Congress. The new bill is also likely to garner more attention for mesothelioma from the medical community, the press, and the public. The Mary […]

Beyond Mesothelioma: Asbestos Linked to Digestive Cancers

249055_older worker

Scientists have long known that mesothelioma, an aggressive cancer that affects the membrane around organs, is not the only cancer linked to asbestos exposure. Numerous studies have also found a link between asbestos and lung cancer. Now, a new study conducted in France and published in Occupational and Environmental Medicine suggests that, in addition to […]

Emerging Therapies Target Mesothelioma in New Ways


Targeted therapies may be the future of mesothelioma treatment. That word comes from a team of some of the world’s top mesothelioma researchers at the University of Hawaii and New York University. The group has just published a review detailing what is known about how mesothelioma develops – also called “pathogenesis” – and how that […]

Putting the Newest Mesothelioma “Orphan Drug” Into Perspective

1115215_lab tech6

Last week, the FDA announced the approval of a new orphan drug for the treatment of malignant pleural mesothelioma. According to drug manufacturer MTG Biotherapeutics, MTG-201 is an “advanced biologic therapy” that targets a particular gene defect present in cancer cells. This defect prevents cells from producing a protein that is critical in apoptosis or programmed […]

Improving Mesothelioma Response to Chemotherapy


Most mesothelioma patients will undergo chemotherapy at some point, whether in preparation for surgery or as a treatment by itself. New research conducted in Italy suggests that it may be possible to make that chemotherapy more effective by manipulating proteins in the cancer cells. Researchers at Salento University in Milan focused on the role of […]

Making Mesothelioma Cells More Susceptible to Chemotherapy


A potential new mesothelioma drug may have moved a step closer to gaining mainstream acceptance for use in sick patients. Doctors studying the drug say they have found a way to make cells more susceptible to its damaging effects. GDC-0980, also known as Apitolisib, is a class I inhibitor of two cell signaling pathways – […]

Irish Physicians Frustrated by Inadequate Training for Mesothelioma Diagnosis

22152824_doctor small

Do general pulmonologists have the training they need to diagnose an illness as rare and challenging as mesothelioma? There is evidence that, at least in Northern Ireland, they do not. A survey conducted of general respiratory physicians in Northern Ireland found that just over a third of the 32 respondents indicated a “lack of confidence […]

Mesothelioma-Causing Power of Asbestos Lingers Long After Contaminating Industry Leaves


There is more evidence that exposure to asbestos can dramatically increase the lifetime odds of developing malignant mesothelioma, even after a contaminating industry has closed its doors. Researchers focused on Casale Monferrato in Northwest Italy, an area known for its high number of mesothelioma cases linked to the Eternit asbestos-cement plant. Although the plant was […]

Could a Virus-Delivered Gene Slow Mesothelioma Growth?


Researchers in Japan are enrolling mesothelioma patients into a trial to test whether blocking a growth signaling pathway inside mesothelioma cells could slow down this aggressive cancer or even stop its progression. The hepatocyte growth factor (HGF)/c-Met signal pathway is highly active in mesothelioma and many other types of cancer cells, telling them to grow and replicate […]